NDASUBCUTANEOUSSOLUTION
Approved
Dec 2021
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
4/8 — Partial
LANREOTIDE ACETATE (lanreotide acetate) by Gen Pharmaceuticals is lanreotide, the active component of lanreotide injection, is an octapeptide analog of natural somatostatin. First approved in 2021.
Drug data last refreshed 5h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Lanreotide Acetate is a somatostatin analog administered via subcutaneous injection that mimics the action of natural somatostatin to suppress hormone secretion. It is used to treat neuroendocrine tumors and acromegaly by inhibiting growth hormone and other peptide hormone release. The drug works by binding somatostatin receptors to reduce pathological hormone levels and tumor growth.
$7MPart D
PeakProduct is in peak commercial phase with modest Part D penetration, indicating a smaller but stable patient base; teams are likely focused on maximizing current market reach rather than rapid expansion.
Mechanism of Action
Lanreotide, the active component of Lanreotide Injection, is an octapeptide analog of natural somatostatin. The mechanism of action of lanreotide is believed to be similar to that of natural somatostatin.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Lanreotide Acetate offers stability in a peak-stage, niche specialty pharmaceutical with a defined patient population and established market position. Career growth potential is moderate, with focus on deep market penetration and patient access optimization rather than launch-phase rapid expansion.
Brand ManagerMedical Science Liaison
Worked on LANREOTIDE ACETATE at Gen Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.